1. Antinociceptive activity of doliroside B.
- Author
-
Bai, Xishan, Li, Yanhong, Li, Yuxiao, Li, Min, Luo, Ming, Tian, Kai, Jiang, Mengyuan, Xiong, Yong, Lu, Ya, Li, Yukui, Yu, Haibo, and Huang, Xiangzhong
- Subjects
- *
GABA receptors , *PERIPHERAL nervous system , *SODIUM dichromate , *TRADITIONAL medicine , *ASPIRIN , *CENTRAL nervous system - Abstract
Dolichos trilobus Linn (Leguminosae) is often used in Yi ethnic medicine to treat pain, fracture, and rheumatism. To explore the therapeutic potential of doliroside B (DB) from D. trilobus and its disodium salt (DBDS) and the underlying mechanism in pain. In the writhing test, Kunming mice were orally treated with DB and DBDS at doses of 0.31, 0.62, 1.25, 2.5, and 5 mg/kg. Vehicle, morphine, indomethacin, and acetylsalicylic acid were used as negative and positive control on the nociception-induced models, respectively. In the hot plate test, mice were orally treated with DB and DBDS at doses of 2.5, 5, 10, and 20 mg/kg. In the formalin test, mice were orally treated with DB and DBDS at doses of 2.5, 5, 10, and 20 mg/kg. In the meanwhile, lipopolysaccharide-induced inflammatory model in RAW264.7 macrophages was adopted to study the mechanism of pain alleviation for DBDS. DBDS (5 mg/kg) inhibited the writhing number by 80.2%, which exhibited the highest antinociceptive activity in pain models. DBDS could selectively inhibite the activity of COX-1. Meanwhile, it also reduced the production of NO, iNOS, and IL-6 by 55.8%, 69.0%, and 49.9% inhibition, respectively. It was found that DBDS also positively modulated the function of GABAA1 receptor. DBDS displayed antinociceptive activity by acting on both the peripheral and central nervous systems, which may act on multitargets. Further work is warranted for developing DBDS into a potential drug for the treatment of pain. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF